Cannabis for Treating IBD: Hope or Hype?
Nausea, abdominal pain and changes in appetite. These are all things that can significantly impact one’s wellbeing if left untreated, yet they have all shown marked improvements when associated with cannabis.
Yet, less is known about the effects of cannabis on inflammatory bowel disease, or IBD, a chronic inflammatory condition that impacts the gastrointestinal tract of over 3.1 million Americans a year.
Michigan Medicine’s Jami Kinnucan, M.D., a gastroenterologist and assistant professor, specializes in IBD, ulcerative colitis, Crohn’s disease and women’s gastrointestinal health. She spoke to Michigan Health about the use of cannabis as a treatment for IBD.
Stories you may be interested in
Insomnia: A Silent Epidemic
The struggle to get a good night’s sleep is something many adults can relate to, but what if there was a natural alternative to keep those sheep jumping all night long? CBD, also known as cannabidiol, has been gaining popularity among patients to help treat pain, anxiety and so much more. Additionally, conditions such as…
Read More 
Medical Marijuana and Cancer
September is dedicated to recognizing numerous cancers that many around the world suffer from, including prostate, thyroid, ovarian and blood cancers. These cancers and many others can produce life-debilitating symptoms and conditions that are difficult to treat with traditional medications. Although there might not be one ‘perfect fix’ when it comes to curing cancer, medical…
Read More 
Data Migration During EMR Changes
One of the most challenging aspects when deciding to switch to a new EMR system is how to get existing data from the old system to the new system safely, securely and accurately. Many times, the scope of this task is enough to force providers to remain with a subpar vendor even though there are…
Read More 
Assessing Health-Related Outcomes of Medical Cannabis Use among Older Persons: Findings from Colorado and Illinois
ABSTRACT Objectives To assess health-related outcomes associated with medical cannabis use among older patients in Colorado and Illinois enrolled in their home state’s medical cannabis program. Methods Cross-sectional data from anonymous surveys were collected from 139 persons over the age of 60 using medical cannabis in the past year. We used structural equation modeling (SEM)…
Read More 
The Lack of Clinical Trials in the Medical Marijuana Industry
As time goes on, medical marijuana is starting to break barriers in various states across the country. Out of the 50 states, 33 have approved a comprehensive medical marijuana program (NCSL). Currently, marijuana, medical or recreational, is illegal at the federal level, despite legalization in various states. Many medical professionals are interested in prescribing medical…
Read More 
Norfolk research company plans clinical trials using medical marijuana
Eighteen months after receiving a broad federal license for importing medical cannabis, a Norfolk research company is about to embark on a series of critical studies into a variety of medical and mental disorders, diseases and conditions. Sanyal Biotechnology is already considering proposals for research campuses and planning its first clinical trial for this summer.…
Read More